Kansas City, MISSOURI3 Active Studies

Chronic Kidney Disease Clinical Trials in Kansas City, MISSOURI

Find 3 actively recruiting chronic kidney disease clinical trials in Kansas City, MISSOURI. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
261
Enrolling

Recruiting Chronic Kidney Disease Studies in Kansas City

About Chronic Kidney Disease Clinical Trials in Kansas City

Chronic kidney disease (CKD) is a progressive loss of kidney function over months or years. It affects about 10% of the global population and can lead to end-stage renal disease requiring dialysis or transplant. Management includes controlling blood pressure, blood sugar, and using newer agents like SGLT2 inhibitors.

There are currently 3 chronic kidney disease clinical trials recruiting participants in Kansas City, MISSOURI. These studies are seeking a combined 261 participants. Research is being sponsored by University of California, Los Angeles, Amgen, Keryx Biopharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.

Chronic Kidney Disease Clinical Trials in Kansas City — FAQ

Are there chronic kidney disease clinical trials in Kansas City?

Yes, there are 3 chronic kidney disease clinical trials currently recruiting in Kansas City, MISSOURI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Kansas City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Kansas City research site will contact you about next steps.

Are clinical trials in Kansas City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Kansas City studies also compensate for your time and travel.

What chronic kidney disease treatments are being tested?

The 3 active trials in Kansas City are testing new therapies including novel drugs, biologics, and treatment approaches for chronic kidney disease.

Data updated March 2, 2026 from ClinicalTrials.gov